The Pharma Data

OCTOBER 19, 2020

DB ( Becton, Dickinson and Company ) received a CE mark for its BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes for assessing immune function in COVID-19 patients. In a challenge trial, people are given a vaccine then intentionally dosed with the virus or bacteria that causes the disease. Please read more here. .

Vaccination 52

Vaccination Vaccine Trials Clinical Trials 52

The Pharma Data

DECEMBER 2, 2020

aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. The new “pathoblocker” treatment aims to disarm pathogens and suppress the disease-causing properties of P.

Drugs 52

Drugs Gene Editing Genome Genomics 52

Drug Discovery World

JULY 18, 2023

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. These efforts, along with many others, are opening doors for new possibilities in translational medicine. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,

DNA 98

DNA Genome Genomics RNA 98

Drug Discovery World

FEBRUARY 15, 2023

The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. Reagents that can augment and enhance ADCC are of interest in addition to the antibodies themselves. Genetically engineered mouse models in oncology research and cancer medicine. doi:10.15252/emmm.201606857pmid:[link]

Research 52

Research In-Vitro In-Vivo Development 52

The Pharma Data

DECEMBER 23, 2020

The agreement includes a £500,000 upfront payment to Avacta which gives Astrea the rights to generate and develop Affimer reagents in-house for affinity separation. BioNTech – Germany’s BioNTech and partner Pfizer secured authorization from the European Medicines Agency for its COVID-19 vaccine. It is a division of Gamma Biosciences.

Drugs 52

Drugs Licensing Licensing Vaccination 52

The Pharma Data

OCTOBER 14, 2020

Prestige BioPharma – Singapore-based Prestige received a positive opinion from the European Medicines Agency Orphan Drug Commission (COMP) for its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer. Talking Medicines – Scotland’s Talking Medicines will join Tech Nation’s Applied AI 2.0

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52